This effect was demonstrated in vitro using human gastric cancer cells MKN45 and AGS, where TRIM44 knockdown reduced β-catenin levels and inhibited Wnt/β-catenin pathway activation [81]. This evidence concerns the gene TRIM44 and gastric cancer.